Trial Details
UNKNOWNBasic Information
| Clinical ID | c1029 |
|---|---|
| Identifier | NCT01011322 |
| Trial Title | A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Large Intestine|Diarrhea|Abdominal Pain |
| Interventions | DRUG: LT-02|DRUG: placebo |
Participant Information
| Sponsor | Lipid Therapeutics GmbH |
|---|---|
| City | Baden-Baden |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-09 |
|---|---|
| Primary Completion Date | 2025-07-11 |
| Completion Date | 2025-02-12 |